COMETRIQ® (Ko-me-trik) cabozantinib capsules What is COMETRIQ? COMETRIQ is a prescription medicine used to treat people with medullary thyroid cancer that has spread to other parts of the body.

COMETRIQ (cabozantinib) capsules are supplied as printed hard gelatin capsules containing cabozantinib (S)-malate equivalent to 20 mg or 80 mg cabozantinib and the following inactive …

Nov 20, 2025 · COMETRIQ (cabozantinib) capsules for oral use are supplied as printed hard gelatin capsules containing cabozantinib (S)-malate equivalent to 20 mg or 80 mg cabozantinib and the …

Do NOT substitute COMETRIQ capsules with cabozantinib tablets. The recommended daily dose of COMETRIQ is 140 mg once daily without food until disease progression or unacceptable toxicity. …

Sep 5, 2023 · Cometriq (Cabozantinib Capsules) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health …

Feb 13, 2025 · Find patient medical information for Cabozantinib (Cabometyx, Cometriq) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Posology COMETRIQ (cabozantinib) capsules and CABOMETYX (cabozantinib) tablets are not bioequivalent and should not be used interchangeably (see section 5.2). The recommended dose of …

Nov 1, 2025 · Do not substitute Cabometyx® tablets with cabozantinib capsules. Do not substitute Cometriq® capsules with cabozantinib tablets. To use the capsules: Take the capsule on an empty …

Aug 13, 2025 · Cabozantinib Generic name: cabozantinib [ KA-boe-ZAN-ti-nib ] Brand names: Cabometyx, Cometriq Dosage forms: oral capsule (20 mg (60 mg daily-dose), 80 mg-20 mg (100 mg …

Medscape - Cancer dosing for Cometriq, Cabometyx (cabozantinib), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information.